Your breath changes are severely impacting your quality of life or nutrition
This provided a promising candidate drug for the treatment of metabolic diseases
The integration of continuous glucose monitors (CGM) with peptide therapy allows real-time feedback on metabolic responses
Fewer crashes
These compounds start AMPK pathways that respond to energy stress
doi: 10.3389/fendo.2025.1501984 Received 26 September 2024 Accepted 25 April 2025 Published 26 May 2025 Volume 16 - 2025 Edited by Hwi Seung Kim, Chung-Ang University Gwangmyeong Hospital, Republic of Korea Reviewed by Andrej Belani, Clinical Hospital Centre Rijeka, Croatia ukasz Budak, Medical University of Silesia, Poland Updates Copyright 2025 Oe, Omori, Aimono, Furukawa, Kitakawa, Tateno, Sakai and Cho